Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.15EUR
108.95 MEUR
1.21 BEUR
50.29 M
About Haemonetics Corporation
Sector
Industry
CEO
Christopher A. Simon
Website
Headquarters
Boston
Founded
1971
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HAZ is 87.00 EUR — it hasn't changed in the past 24 hours. Watch HAEMONETICS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HAEMONETICS CORP stocks are traded under the ticker HAZ.
HAZ stock has fallen by 2.25% compared to the previous week, the month change is a 10.13% rise, over the last year HAEMONETICS CORP has showed a 12.26% increase.
We've gathered analysts' opinions on HAEMONETICS CORP future price: according to them, HAZ price has a max estimate of 116.07 EUR and a min estimate of 87.28 EUR. Watch HAZ chart and read a more detailed HAEMONETICS CORP stock forecast: see what analysts think of HAEMONETICS CORP and suggest that you do with its stocks.
HAZ stock is 0% volatile and has beta coefficient of 0.90. Track HAEMONETICS CORP stock price on the chart and check out the list of the most volatile stocks — is HAEMONETICS CORP there?
Today HAEMONETICS CORP has the market capitalization of 4.46 B, it has increased by 2.78% over the last week.
Yes, you can track HAEMONETICS CORP financials in yearly and quarterly reports right on TradingView.
HAEMONETICS CORP is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
HAZ earnings for the last quarter are 0.83 EUR per share, whereas the estimation was 0.83 EUR resulting in a 0.92% surprise. The estimated earnings for the next quarter are 0.92 EUR per share. See more details about HAEMONETICS CORP earnings.
HAEMONETICS CORP revenue for the last quarter amounts to 318.16 M EUR despite the estimated figure of 305.40 M EUR. In the next quarter revenue is expected to reach 308.54 M EUR.
HAZ net income for the last quarter is 18.88 M EUR, while the quarter before that showed 28.30 M EUR of net income which accounts for −33.31% change. Track more HAEMONETICS CORP financial stats to get the full picture.
No, HAZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HAEMONETICS CORP EBITDA is 279.77 M EUR, and current EBITDA margin is 23.33%. See more stats in HAEMONETICS CORP financial statements.
Like other stocks, HAZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HAEMONETICS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HAEMONETICS CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HAEMONETICS CORP stock shows the buy signal. See more of HAEMONETICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.